Expression Of Certain Enzymes Research Articles

N6-isopentenyladenosine inhibits aerobic glycolysis in glioblastoma cells by targeting PKM2 expression and activity.

Glioblastoma (GBM) is a primary tumor in the central nervous system with poor prognosis. It exhibits elevated glucose uptake and lactate production. This metabolic state of aerobic glycolysis is known as the Warburg effect. N6-isopentenyladenosine (iPA), a natural cytokine modified with an isopentenyl moiety derived from the mevalonate pathway, has well-established anti-tumor activity. It inhibits cell proliferation in glioma cells, inducing cell death by apoptosis and/or necroptosis. In the present study, we found that iPA inhibits aerobic glycolysis in unmodified U87MG cells and in the same cell line engineered to over-express wild-type epidermal growth factor receptor (EGFR) or EGFR variant III (vIII), as well as in a primary GBM4 patient-derived cell line. The detection of glycolysis showed that iPA treatment suppressed ATP and lactate production. We also evaluated the response of iPA treatment in normal human astrocyte primary cells, healthy counterpart cells of the brain. Aerobic glycolysis in treated normal human astrocyte cells did not show significant changes compared to GBM cells. To determine the mechanism of iPA action on aerobic glycolysis, we investigated the expression of certain enzymes involved in this metabolic pathway. We observed that iPA reduced the expression of pyruvate kinase M2 (PKM2), which plays a key role in the regulation of aerobic glycolysis, promoting tumor cell proliferation. The reduction of PKM2 expression is a result of the inhibition of the inhibitor of nuclear factor kappa-B kinase subunit, beta/nuclear factor-kappa B pathway upon iPA treatment. In conclusion, these experimental results show that iPA may inhibit aerobic glycolysis of GBM in stabilized cell lines and primary GBM cells by targeting the expression and activity of PKM2.

Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases.

Disturbed hepatic energy metabolism contributes to non-alcoholic fatty liver (NAFLD), but the development of changes over time and obesity- or diabetes-related mechanisms remained unclear. Two-day old male C57BL/6j mice received streptozotocin (STZ) or placebo (PLC) and then high-fat (HFD) or regular chow diet (RCD) from week 4 (W4) to either W8 or W16, yielding control [CTRL=PLC+RCD], diabetes [DIAB=STZ+RCD], obesity [OBES=PLC+HFD] and diabetes-related non-alcoholic steatohepatitis [NASH=STZ+HFD] models. Mitochondrial respiration was measured by high-resolution respirometry and insulin-sensitive glucose metabolism by hyperinsulinemic-euglycemic clamps with stable isotope dilution. NASH showed higher steatosis and NAFLD activity already at W8 and liver fibrosis at W16 (all p<0.01 vs CTRL). Ballooning was increased in DIAB and NASH at W16 (p<0.01 vs CTRL). At W16, insulin sensitivity was 47%, 58% and 75% lower in DIAB, NASH and OBES (p<0.001 vs CTRL). Hepatic uncoupled fatty acid oxidation (FAO)-associated respiration was reduced in OBES at W8, but doubled in DIAB and NASH at W16 (p<0.01 vs CTRL) and correlated with biomarkers of unfolded protein response (UPR), oxidative stress and hepatic expression of certain enzymes (acetyl-CoA carboxylase 2, Acc2; carnitine palmitoyltransferase I, Cpt1a). Tricarboxylic acid cycle (TCA)-driven respiration was lower in OBES at W8 and doubled in DIAB at W16 (p<0.0001 vs CTRL), which positively correlated with expression of genes related to lipolysis. Hepatic mitochondria adapt to various metabolic challenges with increasing FAO-driven respiration, which is linked to dysfunctional UPR, systemic oxidative stress, insulin resistance and altered lipid metabolism. In a diabetes model, higher TCA-linked respiration reflected mitochondrial adaptation to greater hepatic lipid turnover. Funding bodies that contributed to this study were listed in the acknowledgements section.

Influence of redox potential on the accumulation of poly(3-hydroxybutyrate) by Bacillus megaterium.

The main goal of the present study was to evaluate the oxidation-reduction potential (ORP) on the production of poly(3-hydroxybutyrate) (P(3HB)) by Bacillus megaterium. Each microorganism has an optimal ORP range, and changes to the culture medium's ORP may redistribute the cell's metabolic flux, as such, the measurement and control of the ORP profile allows one to, in a way, manipulate the microbial metabolism, affecting the expression of certain enzymes and allowing for better control over the fermentative process. The ORP tests were carried out in a fermentation vessel coupled with an ORP probe, containing 1L of mineral medium added with agroindustry byproducts (60% v/v of confectionery wastewater, and 40% v/v of rice parboiling water). The system's temperature was kept at 30°C, with an agitation speed of 500rpm. The vessel's airflow rate was controlled via a solenoid pump based on the ORP probe's data. Different ORP values were evaluated to verify their impact on biomass and polymer production. Cultures using OPR levels of 0mV displayed the highest amounts of total biomass (5.00gL-1) when compared to -20mV and -40mV (2.90g L-1 and 0.53g L-1, respectively). Similar results were also found for P(3HB)-to-biomass ratio, with polymer concentration being reduced when using ORP levels below 0mV and with a maximum amount of polymer-to-biomass ratio of 69.87% after 48h of culture. Furthermore, it was possible to observe that the culture's pH can also affect total biomass and polymer concentration, albeit to a lesser extent. Thus, when considering the data found during this study, it is possible to observe that ORP values can greatly impact B. megaterium cell's metabolism. Furthermore, the measurement and control of ORP levels may be an invaluable asset when trying to maximize polymer production under different culture conditions.

Genotyping and plant-derived glycan utilization analysis of Bifidobacterium strains from mother-infant pairs

BackgroundBifidobacteria are important probiotics; some of the beneficial effects of bifidobacteria are achieved by the hydrolysis of glycans in the human gut. However, because the diet of breastfed infants typically lacks plant-derived glycans, in the gut environment of mothers and their breastfed infants, the mother will intake a variety of plant-derived glycans, such as from onions and bananas, through her diet. Under this assumption, we are interested in whether the same species of bifidobacteria isolated from mother-infant pairs present a distinction in their hydrolysis of plant-derived carbohydrates.ResultsAmong the 36 Bifidobacterium strains, bifidobacterial carbohydrate utilization showed two trends related to the intestinal environment where the bacteria lived. Compared with infant-type bifidobacterial strains, adult-type bifidobacterial strains preferred to use plant-derived glycans. Of these strains, 10 isolates, 2 Bifidobacterium pseudocatenulatum (B. pseudocatenulatum), 2 Bifidobacterium pseudolongum (B. pseudolongum), 2 Bifidobacterium bifidum (B. bifidum), 2 Bifidobacterium breve (B. breve), and 2 Bifidobacterium longum (B. longum), were shared between the mother-infant pairs. Moreover, the repetitive sequence-based polymerase chain reaction (rep-PCR) results illustrated that B. pseudolongum and B. bifidum showed genotypic similarities of 95.3 and 98.2%, respectively. Combined with the carbohydrate fermentation study, these results indicated that the adult-type strains have a stronger ability to use plant-derived glycans than infant-type strains. Our work suggests that bifidobacterial carbohydrate metabolism differences resulted in the selective adaptation to the distinct intestinal environment of an adult or breastfed infant.ConclusionsThe present study revealed that the different gut environments can lead to the differences in the polysaccharide utilization in the same strains of bifidobacterial strains, suggesting a further goal of investigating the exact expression of certain enzymes in response to specific carbon sources.

Microbial enzymes for deprivation of amino acid metabolism in malignant cells: biological strategy for cancer treatment.

Amino acid deprivation therapy (AADT) is emerging as a promising strategy for the development of novel therapeutics against cancer. This biological therapy relies upon the differences in the metabolism of cancer and normal cells. The rapid growth of tumors results in decreased expression of certain enzymes leading to auxotrophy for some specific amino acids. These auxotrophic tumors are targeted by amino acid-depleting enzymes. The depletion of amino acid selectively inhibits tumor growth as the normal cells can synthesize amino acids by their usual machinery. The enzymes used in AADT are mostly obtained from microbes for their easy availability. Microbial L-asparaginase is already approved by FDA for the treatment of acute lymphoblastic leukemia. Arginine deiminase and methionase are under clinical trials and the therapeutic potential of lysine oxidase, glutaminase and phenylalanine ammonia lyase is also being explored. The present review provides an overview of microbial amino acid depriving enzymes. Various attributes of these enzymes like structure, mode of action, production, formulations, and targeted cancers are discussed. The challenges faced and the combat strategies to establish AADT in standard cancer armamentarium are also reviewed.Key Points • Amino acid deprivation therapy is a potential therapy for auxotrophic tumors. • Microbial enzymes are used due to their ease of manipulation and high productivity. • Enzyme properties are improved by PEGylation, encapsulation, and genetic engineering. • AADT can be employed as combinational therapy for better containment of cancer.

Development of Versatile Vectors for Heterologous Expression in Bacillus.

The discovery of new enzymes for industrial application relies on a robust discovery pipeline. Such a pipeline should facilitate efficient molecular cloning, recombinant expression and functional screening procedures. Previously, we have developed a vector set for heterologous expression in Escherichia coli. Here, we supplement the catalogue with vectors for expression in Bacillus. The vectors are made compatible with a versatile cloning procedure based on type IIS restriction enzymes and T4 DNA ligase, and encompass an effective counter-selection procedure and complement the set of vectors with options for secreted expression. We validate the system with expression of recombinant subtilisins, which are generally challenging to express in a heterologous system. The complementarity of the E. coli and Bacillus systems allows rapid switching between the two commonly used hosts without comprehensive intermediate cloning steps. The vectors described are not limited to the expression of certain enzymes, but could also be applied for the expression of other enzymes for more generalized enzyme discovery or development.

Is there an association between ABO blood type and ovarian reserve in women undergoing intrauterine insemination (IUI)±ovulation induction (OI)?

It has been hypothesized that differential expression of certain enzymes (such as A-transferase) among different ABO blood groups might play a vital role in oocyte accrual and attrition. Furthermore, genes impacting ovarian reserve have been localized in close proximity with the ABO locus and are therefore more commonly inherited together. For these reasons, it is theoretically possible that a correlation between ABO blood types and ovarian reserve exists. Emerging studies exploring this possibility report contradictory results.

Induction of ischemic tolerance as a promising treatment against diabetic retinopathy.

Diabetic retinopathy is a leading cause of acquired blindness, and it is the most common ischemic disorder of the retina. Available treatments are not very effective. Efforts to inhibit diabetic retinopathy have focused either on highly specific therapeutic approaches for pharmacologic targets or using genetic approaches to change expression of certain enzymes. However, it might be wise to choose innovative treatment modalities that act by multiple potential mechanisms. The resistance to ischemic injury, or ischemic tolerance, can be transiently induced by prior exposure to a non-injurious preconditioning stimulus. A complete functional and histologic protection against retinal ischemic damage can be achieved by previous preconditioning with non-damaging ischemia. In this review, we will discuss evidence that supports that ischemic conditioning could help avert the dreaded consequences that results from retinal diabetic damage.

Detergents with different chemical properties induce variable degree of cytotoxicity and mRNA expression of lipid-metabolizing enzymes and differentiation markers in cultured keratinocytes

The knowledge how detergents with different chemical properties influence epidermal keratinocytes is sparse. In the present study, the effects of five detergents were examined with respect to cell-toxicity and mRNA expression of key-enzymes in barrier lipid production and keratinocyte differentiation markers. First, the LD 50 for each detergent were determined. Secondly, keratinocytes were exposed to sub-toxic concentrations and the mRNA expression was analysed by real-time PCR after 24 h exposure to the detergents. SLS and CAPB induced a concentration-dependent increase in the expression of enzymes producing cholesterol and ceramides, while transcripts of enzymes producing fatty acids were unaffected. SLES and cocoglucoside increased the expression of certain enzymes involved in cholesterol and fatty acid synthesis while sodium cocoamphoacetate (SCAA) stimulated expression of transcripts involved in fatty acid synthesis. The expression of differentiation markers were increased by SLS, SLES and CAPB, while SCAA and cocoglucoside exhibited no effect. The present findings show that detergents have variable effects on lipid synthesis and keratinocyte differentiation, which could partly explain their barrier destruction potential in vivo.

Topiramate does not alter expression in rat brain of enzymes of arachidonic acid metabolism

When administered chronically to rats, drugs that are effective in bipolar disorder-lithium and the anticonvulsants, valproic acid and carbamazepine-have been shown to downregulate the expression of certain enzymes involved in brain arachidonic acid (AA) release and cyclooxygenase (COX)-mediated metabolism. Phase II clinical trials with the anticonvulsant topiramate [2,3:4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate] suggest that this drug may also be effective for bipolar disorder. To see if topiramate has effects similar to those of the other three drugs, we administered topiramate to rats for 14 days at 20 mg/kg, p.o. twice daily. Compared with p.o. vehicle, topiramate treatment did not significantly affect the brain activity or protein level of cytosolic phospholipase A2, secretory PLA2, or Ca2+-independent iPLA2. Additionally, brain protein levels of COX-1, COX-2, 5-lipoxygenase, and cytochrome P450 epoxygenase were unchanged. These results suggest that topiramate does not modify expression of the enzymes involved in brain AA metabolism that have been shown to be targeted by lithium, valproic acid, or carbamazepine. If topiramate proves effective in bipolar disorder, it may not act by modulating brain AA metabolism. In view of the proven anticonvulsant effect of topiramate, our results also suggest that the AA cascade is not involved in the anti-seizure properties of the drug.

Free and microencapsulated Lactobacillus and effects of metabolic induction on urea removal.

We have previously reported the experimental use of genetically engineered Escherichia coli with microencapsulation to lower nitrogenous waste. Concern has surfaced, nonetheless, about safety of genetically engineered product. The purpose of this study is to explore the alternative use of probiotics in removal of plasma urea. After repeated cycles of exposure of Lactobacillus delbrueckii in urea-rich medium under anaerobic environment, the organisms were demonstrated to lower plasma urea concentration in vitro. Suspension of Lactobacillus in uremic plasma reduced the urea nitrogen levels from 51.5 +/- 5.2 mg/dL to 44.3 +/- 3.9 mg/dL (P = 0.02) after 24 hours. With microencapsulation of Lactobacillus (inside semipermeable alginate-polylysine-alginate polymeric membrane), further lowering of urea nitrogen levels was achieved (35.4 +/- 0.8 mg/dL, P = 0.03) at 24 hours. These preliminary data show that expression of certain enzymes could be induced in Lactobacillus delbrueckii and thus capable of lowering plasma urea. Further studies and molecular analysis would be indicated to explore and refine the techniques.

Ectoenzymatic activity and bacterial dynamics along a trophic gradient in the Caribbean Sea

Bacterial biomass, potential bacterial production and ectoenzymatic activity were measured at 4 stations along a trophic gradient at the Atlantic Barrier Reef off Belize (Central America). We investigated the changes in the trophic status of this system, which we hypothesized would also lead to changes in the bacterial community. The bacterial community of the oligotrophic station was characterized by low biomass (mean 7.2 pg C 1-') and low potential production rates (mean 9.2 pg C l-Id') as determined by seawater cultures whereas at the most eutrophic station bacterial biomass (mean 18.6 pg C I ' ) as well as potential bacterial production (mean 15.5 pg C I-' d-l) was significantly higher. Oligotrophic bacteria exhibit high potential turnover rates (1.5 dl) . Ectoenzymatic activity measurements with fluorogenic-substrate analogs showed distinct differences in the expression of certain enzymes at different trophic conditions. aand P-D-glucosidase activity declined from eutrophic to oligotrophic in both per volume and per cell while leucine-aminopeptidase activity per cell was inversely correlated with the trophic status of the environment. Differences in ectoenzymatic activity are indicated by differences in both v,,,,, and K,. K,,, values of leucine-aminopeptidase clearly reflect the trophic situation. Substrate affinity was found to be higher in oligotrophic waters by 2 orders of magnitude as compared to eutrophic environments. Potential activity (v,,,,) of the extracellular enzymes tested was found to be correlated to potential bacterial production and bacterial biomass.

Ectoenzymatic activity and bacterial dynamics along a trophic gradient in the Caribbean Sea

Bacterial biomass, potential bacterial production and ectoenzymatic activity were measured at 4 stations along a trophic gradient at the Atlantic Barrier Reef off Belize (Central America). We investigated the changes in the trophic status of this system, which we hypothesized would also lead to changes in the bacterial community. The bacterial community of the oligotrophic station was characterized by low biomass (mean 7.2 pg C 1-') and low potential production rates (mean 9.2 pg C l-Id') as determined by seawater cultures whereas at the most eutrophic station bacterial biomass (mean 18.6 pg C I ' ) as well as potential bacterial production (mean 15.5 pg C I-' d-l) was significantly higher. Oligotrophic bacteria exhibit high potential turnover rates (1.5 dl) . Ectoenzymatic activity measurements with fluorogenic-substrate analogs showed distinct differences in the expression of certain enzymes at different trophic conditions. aand P-D-glucosidase activity declined from eutrophic to oligotrophic in both per volume and per cell while leucine-aminopeptidase activity per cell was inversely correlated with the trophic status of the environment. Differences in ectoenzymatic activity are indicated by differences in both v,,,,, and K,. K,,, values of leucine-aminopeptidase clearly reflect the trophic situation. Substrate affinity was found to be higher in oligotrophic waters by 2 orders of magnitude as compared to eutrophic environments. Potential activity (v,,,,) of the extracellular enzymes tested was found to be correlated to potential bacterial production and bacterial biomass.

Phenotypic variation of Staphylococcus epidermidis isolated from a patient with native valve endocarditis

Two colonial variants of Staphylococcus epidermidis were isolated from the valvular tissue of a patient with native valve endocarditis. In addition to differing in colonial morphology, the two variants differed in hemolysis on blood-containing media, in adherence capacity, and in the expression of certain enzymes. Under suitable conditions, both variants were themselves capable of phenotypic variation, although they differed in the rate at which variants were generated. The variants yielded identical profiles on restriction endonuclease analysis of plasmid DNA and pulsed-field gel electrophoresis of whole-cell DNA. This report suggests a possible role for phenotypic variation in coagulase-negative staphylococcal virulence. Congo red agar would be an excellent medium for studying the contribution of variation to the virulence of these organisms.